Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference Biotech Investing
HCW Biologics Inc. Participates in Virtual Investor "What This Means" Segment About its Proprietary T-Cell Engager Program Biotech Investing
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer's Disease Trial Biotech Investing
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia Biotech Investing
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, "Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets", in New York on October 14, 2025 Biotech Investing
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial Biotech Investing
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs Biotech Investing
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Biotech Investing
